Daniel Turner III Net Worth & Insider Trades

Daniel Turner III - Director, Transcept Pharmaceuticals Inc

As of March 30, 2011

What is Daniel Turner III's Net Worth?

The current estimated net worth of Transcept Pharmaceuticals Inc's Director, Daniel Turner III, is estimated to be about $5.03M . Daniel Turner III owns about 627,539 units of Transcept Pharmaceuticals Inc common stock. In the last 2 years at Transcept Pharmaceuticals Inc, Daniel Turner III has sold an estimated value of $2.05M worth.

What is Daniel Turner III's Past Insider Trading?

Daniel Turner III's largest sale order was 130,000 units , worth over $1.06M on March 30, 2011. In total, Daniel Turner III has made about 7 transactions over 2 years of their time at Transcept Pharmaceuticals Inc. Daniel Turner III usually trades in February, January and September, with the busiest year in 2009.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DANIEL TURNER III

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Daniel Turner III's' Mailing Address?

  • Mailing address is 2500 Sand Hill Road 215 Menlo Park CA 94025 CA

What are Transcept Pharmaceuticals Inc's Past Insider Trades?

Transcept Pharmaceuticals Inc's most recent insider trade came on December 17, 2013 by Roumell Asset Management Llc who sold 1,470 units worth $5.2K . In the last 4 years, insiders at Transcept Pharmaceuticals Inc have sold an estimated value of $6.52M and bought an estimated value of $9.99M worth of shares. Insider trading is most common in February, with the busiest year in 2011. The most active traders at the company are Roumell Asset Management Llc,  Glenn Oclassen, President and CEO,  and Marilyn Wortzman, VP .

Transcept Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...